Paper29068496
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
Amiche MA and 4 others. J Bone Miner Res, 2018. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses. Papers, record 29068496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29068496
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diphosphonates | Major topic |
| Fractures, Bone | Major topic |
| Glucocorticoids | Major topic |
| Administration, Oral | |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Female | |
| Humans | |
| Male | |
| Risk Factors | |
| Treatment Outcome |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41954168 | Underutilization of Osteoporosis Screening in Patients With Severe COPD and Long Term Corticosteroid Use. | J Prim Care Community Health | 2026 | https://conductscience.org/library/papers/41954168 | PubMed |
| 41396571 | Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review. | Drugs Aging | 2026 | https://conductscience.org/library/papers/41396571 | PubMed |
| 40935429 | PRevEnting FracturEs in REnal Disease-1 (PREFERRED-1): protocol for a pilot study of a pragmatic, randomised controlled trial of denosumab for the prevention of fragility fractures in haemodialysis. | BMJ Open | 2025 | https://conductscience.org/library/papers/40935429 | PubMed |
| 40906172 | The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/40906172 | PubMed |
| 38516640 | Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users. | SAGE Open Med | 2024 | https://conductscience.org/library/papers/38516640 | PubMed |
| 37881495 | Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37881495 | PubMed |
| 37253115 | Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad? | Endocr Rev | 2023 | https://conductscience.org/library/papers/37253115 | PubMed |
| 36961031 | Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data. | Pharmacy (Basel) | 2023 | https://conductscience.org/library/papers/36961031 | PubMed |
| 36856881 | Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids. | Arch Osteoporos | 2023 | https://conductscience.org/library/papers/36856881 | PubMed |
| 35757436 | Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35757436 | PubMed |
| 35203613 | Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203613 | PubMed |
| 34975756 | When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34975756 | PubMed |
| 34830959 | Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830959 | PubMed |
| 33803095 | Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making. | J Clin Med | 2021 | https://conductscience.org/library/papers/33803095 | PubMed |
| 33415374 | Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use. | Osteoporos Int | 2021 | https://conductscience.org/library/papers/33415374 | PubMed |
| 33080717 | Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/33080717 | PubMed |
| 32253606 | Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway. | Med Mol Morphol | 2021 | https://conductscience.org/library/papers/32253606 | PubMed |
| 31565078 | Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice. | Ther Adv Musculoskelet Dis | 2019 | https://conductscience.org/library/papers/31565078 | PubMed |
| 31201710 | Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis. | Drugs | 2019 | https://conductscience.org/library/papers/31201710 | PubMed |
| 29691807 | Glucocorticoid-induced osteoporosis: an update. | Endocrine | 2018 | https://conductscience.org/library/papers/29691807 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29068496
GET https://conductscience.org/api/papers/v1/29068496/authors